At our preliminary experiment, we demonstrated quantum regeneration of a dog’s tooth using laser technology based on an expanded understanding of genetic coding principles that predict quantum equivalents of genes working. Multipotent mesenchymal stem cells were pretreated with human tooth rudiment quantum genetic information before injection into an extraction site; while an adjacent control symmetrical area remained untreated.
Getting Started with Genetic Testing
If you’re interested in genetic testing, the first step should always be consulting with a healthcare provider. They will be able to explain all of the risks and benefits involved and might even help arrange insurance coverage of the test itself. As most serious illnesses have genetic components that must be taken into consideration when making decisions about treatment or preventative care plans, knowing your risk profile is vitally important.
Your choice of genetic test will depend on what information you seek. Some tests focus on one variant in a gene and are typically used to detect familial diseases like sickle cell anemia; direct-to-consumer testing companies typically offer multivariant tests which can reveal subtler variations that could indicate disease susceptibility.
An effective genetic test should provide clear explanations and actionable steps that can be taken based on its results, with ACMG guidelines serving as the basis of classification of mutations as pathogenic, likely pathogenic, variant of undetermined significance (VUS), or benign being adhered to. Furthermore, speaking to a genetic counselor regarding interpretation is also desirable.
Genetic tests can not only identify inherited mutations that cause disease, but they can also reveal how certain drugs and medical treatments may impact you – providing more informed decisions to make with your healthcare provider.
Many genetic tests can be conducted at home using a saliva or cheek swab kit, and then sent to a lab for analysis. Home testing tends to cost less than health care settings; cheaper kits may even come from direct-to-consumer companies offering additional services like tracking ancestry or traits sections relating to visible characteristics (phenotypes).
Most health tests don’t give actionable information, but MyToolbox Genomics, InsideTracker and Nebula Genomics offer actionable genetic insights for less blood. Their kits conduct more comprehensive analyses by looking at more genes and chromosomes – with meal plans, training regimens and vitamin recommendations provided accordingly. Plus they typically come equipped with privacy policies that ensure your results won’t be used by employers or insurers!
Getting Started with Prenatal Testing
Prenatal testing provides parents-to-be with essential information they need for informed decisions before, during, and after pregnancy. Accurate information helps mothers prepare their fetuses for an easy gestation experience while genetic screening tests and prenatal diagnostic testing give you more chance of an ideal birth for your unborn baby.
At your routine prenatal visits, we monitor your weight and blood pressure; monitor fetal development; listen to and interpret fetal heartbeat sounds; discuss any issues or questions; perform pelvic exams to screen for signs of infection; recommend tests such as Hepatitis B/C/GnRHa (chlamydia/gonorrhea/HIV (the virus that causes AIDS); as well as perform vaginal exams to screen for signs of infection depending on your age, medical history and risk factors; perform pelvic/vaginal exams to screen for signs of infection as well. Depending on these factors we may recommend testing services such as Hepatitis B/C/CHLAmydia/GnRHa testing (with regards to either/addition).
In the first trimester, we can help determine your baby’s sex by analyzing small fragments of DNA circulating in your mother’s bloodstream from the placenta. Cell-free DNA testing – commonly referred to as noninvasive prenatal screening or NIPS/NIPT) – is used to detect trisomies which increase risk for Down syndrome and other chromosomal abnormalities as well as whether you’re more likely to give birth to a boy or girl. NIPT may start as early as nine weeks but for optimal results we prefer starting it after nine weeks for optimal sample sizes.
Carrier screening can help identify whether you and your partner have an increased risk of having a baby with certain genetic conditions such as sickle cell disease, cystic fibrosis or spinal muscular atrophy. Your OBGYN will discuss all available carrier screening panels that best match up to your family history and ethnic background to find one suitable to you.
As soon as your second trimester approaches, we offer more comprehensive ultrasound examination of your baby’s anatomy to screen for open neural tube defects and specific chromosomal disorders. Amniocentesis or Chorionic Villus Sampling (CVS) may also be performed to diagnose chromosomal abnormalities and other health conditions by collecting an amniotic fluid sample from your fetus; these diagnostic procedures may only be suggested if NIPS or prenatal serum screening results indicate an elevated risk for certain disorders or conditions and you wish to pursue further evaluation.
Getting Started with Pregnancy Testing
Acquiring accurate prenatal screening and genetic testing results are vitally important, both during and after gestation. By providing you with more informed plans for a healthy gestation and delivery.
If you are at an increased risk for certain conditions, your doctor may advise genetic testing before or during the first trimester of pregnancy. Such testing can identify whether you carry genes for cystic fibrosis or Tay-Sachs disease that will likely pass onto your offspring; or determine if you’re carrying mutations that could impact their development like sickle cell disease or Gaucher disease – an invaluable service which is best employed during this phase when your chances of having healthy babies increase dramatically.
Some ob-gyns offer integrated or comprehensive screening tests that give an estimate of your overall risk for chromosomal disorders based on maternal age, ultrasound results and blood test data. The CDC strongly suggests this screening for women of any age who have experienced previous miscarriages, have family histories with genetic disease or chromosomal disorders and/or have other risk factors.
Cell-free fetal DNA testing offers more accurate predictions of your baby’s risk for chromosomal disorders by measuring fetal cells in mother’s blood to detect conditions like Down syndrome, trisomy 13 and trisomy 18 more reliably than screening alone during weeks 16-20 of gestation. This test should be performed between weeks 16-20 of gestation.
If your ob-gyn recommends this test, two procedures will need to be completed: amniocentesis involves inserting a needle into your abdomen in order to obtain amniotic fluid that contains genetic material for analysis by testing for chromosomal abnormalities; and chorionic villus sampling (CVS), which extracts small cells from your placenta at around weeks 10-13 when your baby has more chances of survival.
